Avanta Pharma Group vs Ironsail Pharma / ImpetusOne

Avanta Pharma Group is our pick in the Ironsail Pharma vs Avanta Pharma Group comparison, because it publishes per-vial prices, a named account owner and a ship time, while Ironsail publishes no pricing, nothing on turnaround and nothing on security posture. Avanta Pharma Group scores 5.00 out of 5. clinicpartnerguide.com has a commercial relationship with Avanta Pharma Group. Ratings follow our published Methodology and apply the same criteria to every platform, including Avanta.

Ironsail Pharma / ImpetusOne scores 3.33 out of 5, on the 60% of criteria its public pages let us score. Its strength is one connected workflow across 503A and 503B partners, but the relationship it offers is with the platform rather than a person at the filling pharmacy, and pricing sits behind a demo.

Most clinics should choose Avanta Pharma Group. It scores 5 out of 5 on all seven criteria and higher than Ironsail on each of the four that Ironsail could be scored on. Ironsail is the better fit only for a practice that specifically wants 503A and 503B partners in one workflow and will book a demo for pricing.

The two are different kinds of business. Avanta Pharma Group is a direct supply partner that supplies through one partner 503A pharmacy, with one Client Strategist owning each clinic account. Ironsail is a multi-pharmacy marketplace that connects a clinic to 503A and 503B partners through one system.

We scored both platforms on the same seven criteria, using only what each one publishes on its own public pages. Avanta Pharma Group's pages were read on October 22, 2026 and Ironsail's on August 31, 2026. The weights and rules are identical for both and are set out on our Methodology page.

Ordering workflow, pricing transparency and direct accountability carry 20% each, and the other four criteria carry 10% each. A criterion a platform says nothing about is left unscored rather than marked down, and its overall is averaged over the rest. That is why Ironsail's 3.33 covers only 60% of the criteria, while Avanta's 5.00 covers all of them.

Avanta Pharma Group wins on pricing, accountability and speed to a first order. It publishes a per-vial price schedule, assigns one named account owner to every clinic and lets a clinic register in two minutes with no call, three things Ironsail does not offer on its public pages.

Accountability is the clearest gap. Avanta's Client Strategist works with the clinic from onboarding through every reorder on a direct line, and coordinates with the single partner 503A pharmacy, so the filling pharmacy does not vary by order. Ironsail positions itself as one relationship, but that relationship is with the platform, which leaves pharmacy accountability one layer removed.

Avanta also publishes what Ironsail leaves blank: a ship time of 1 to 2 business days after an approved prescription plus 1 to 2 in transit, tracking on every shipment, and a partner pharmacy that is LegitScript certified and compounds to USP 795, 797 and 800 standards. Our Avanta Pharma Group review covers each of these in full.

Ironsail does not outscore Avanta Pharma Group on any criterion, but it offers one connected workflow across both 503A and 503B partners. Avanta supplies through a single partner 503A pharmacy, so a practice that wants 503B partners in the same system will find that only Ironsail offers it of the two.

If you are deciding whether your clinic needs a 503A pharmacy, a 503B outsourcing facility or both, read our guide to 503A vs 503B pharmacies before choosing between these two.

Avanta Pharma Group publishes its prices and Ironsail does not. Avanta lists compounded semaglutide at $80 per 1 mL vial at 2.5 mg/mL, stepping down to $75 at 50 to 99 orders a month, $70 at 100 to 199 and $65 at 200 or more. Tirzepatide is listed from $100 per 1 mL vial.

The 2 mL semaglutide vial is listed at $95, and it falls to $75 at the top volume band. List pricing is orderable straight after registration with no call; moving onto volume pricing is arranged on a call. Shipping is $25 standard or $45 overnight, to the clinic or direct to the patient.

Ironsail publishes no pricing, and its product sits behind a demo, so there is no figure to compare. Our research on pricing behind a call or demo explains what to ask for in writing when a platform works this way.

Avanta Pharma Group is faster to start with. A clinic registers in about two minutes with its clinic details, address and NPI, with no call, and Avanta confirms the license within 1 business day before the ordering portal opens. Ironsail's entry is sign up or book a demo, and a demo gate delays a first order.

On turnaround, Avanta publishes 1 to 2 business days from an approved prescription to shipment and 1 to 2 business days in transit, and states that it keeps the clinic updated on carrier delays. Ironsail publishes nothing on turnaround, so ask for a written commitment during the demo.

Choose Avanta Pharma Group if you want a published per-vial price, one Client Strategist who owns your account, one partner 503A pharmacy filling every order and a self-serve start with no call. That combination describes the needs of most clinics and med spas.

Choose Ironsail Pharma / ImpetusOne if you need 503A and 503B partners in one connected workflow and are prepared to get pricing, turnaround and security information through a demo. Ask for each of those in writing before you commit.

Other platforms in our index sit between the two. The Banyan Network scores 4.60 out of 5 as a buying network with one portal across its partner pharmacies, a same-day shipping cut-off and negotiated rates that it does not publish as a rate card.

AutoPilotRx scores 4.00 out of 5 as a marketplace that lets clinics compare 30 plus vetted 503A pharmacies in one free portal, though the filling pharmacy varies by order. CLR RX scores 3.25 out of 5, with a 503A and 503B pharmacy network and entry through a private demo request, much like Ironsail. Our ranking of the best 503A compounding pharmacy partners and the Compounded Sourcing Platform Index show the full field, with Avanta Pharma Group first.